Corporate Insight

Announcement

Company Xiwang Pharmaceutical
Xiwang Pharmaceutical

Xiwang Pharmaceutical owns the world’s largest specialized production workshop for glucose and anhydrous glucose, and keeps deepening the pharmaceutical raw material field relying on the whole industrial chain advantages. In 2012, the company invested 60 million yuan in core technological renovation, taking the lead in introducing continuous ion exchange technology. Through process innovation, we reduced material cost by 50% and washing water consumption by 70%, achieving landmark results in energy conservation, green production and cost reduction, further consolidating the efficient and low-carbon production system.

In 2017, the company invested 600 million yuan to build a new high-standard production workshop, fully compliant with EU production standards and international pharmaceutical raw material requirements. Equipped with advanced DCS industrial automation control system and Profibus bus technology, the workshop realizes digital and intelligent control of the whole production process, greatly improving production efficiency, product accuracy and supply stability. With world-class production standards, we provide high-quality and high-safety core raw material support for the global pharmaceutical industry.